We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| AstraZeneca PLC | NASDAQ:AZN | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.6401 | 0.84% | 76.9601 | 76.96 | 76.97 | 77.16 | 76.61 | 76.77 | 2,025,707 | 18:26:41 |
From May 2019 to May 2024
A University of Cambridge analysis showed vaccination would prevent seven intensive-care admissions over a four-month period if new daily cases were detected at 200 per 100,000 people, and that it would prevent 0.8 admissions if daily cases were 20 per 100,000. "Can the AstraZeneca Vaccine Cause Blood Clots? What You Need to Know," at 10:46 ET, incorrectly said seven and 0.8 admissions would be expected per 100,000 people over the four-month period, and misstated the ratio of cases in the second example as 0.2 per 100,000.
(END) Dow Jones Newswires
April 08, 2021 13:46 ET (17:46 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year AstraZeneca Chart |
1 Month AstraZeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
